WLKP Q4 2025 Earnings Call Summary | Stock Taper
Logo
WLKP

WLKP — Westlake Chemical Partners LP

NYSE


Q4 2025 Earnings Call Summary

February 24, 2026

Summary of Westlake Chemical Partners Q4 2025 Earnings Call

1. Key Financial Results and Metrics

  • Q4 2025 Net Income: $15 million, or $0.41 per unit.
  • Full Year 2025 Net Income: $49 million, or $1.38 per unit, down from $62 million in 2024.
  • Consolidated Net Income (including OpCo): $84 million for Q4 and $299 million for the full year.
  • Distributable Cash Flow (DCF): $19 million for Q4 2025 ($0.53 per unit), up from $15 million in Q4 2024; full year DCF was $53 million, down from $67 million in 2024.
  • Distribution Coverage Ratio: 0.8x for the full year 2025, reflecting a dip below 1x due to planned turnarounds.

2. Strategic Updates and Business Highlights

  • The partnership's earnings are supported by a fixed margin ethylene sales agreement covering 95% of annual production, providing stability against market volatility.
  • Successful renewal of the ethylene sales agreement with Westlake through 2027 under unchanged terms, highlighting the critical nature of OpCo's ethylene supply.
  • The partnership has maintained a strong balance sheet with a consolidated cash balance of $68 million and a long-term debt of $400 million.
  • The company has paid 46 consecutive quarterly distributions since its IPO in July 2014, with a 71% increase in distributions since the original minimum.

3. Forward Guidance and Outlook

  • No planned turnarounds in 2026 are expected to lead to improved production and sales volumes, which should enhance distributable cash flow and coverage ratios.
  • Management anticipates the coverage ratio to rise above 1.1x in 2026, supported by a strong operating surplus and cash reserves.

4. Bad News, Challenges, or Points of Concern

  • Full year net income decreased by $13 million compared to 2024, primarily due to lower production and sales volumes from the planned Petro 1 turnaround.
  • The coverage ratio dipped below 1x, which is typically concerning, though management expects recovery in 2026.
  • The reliance on ethylene sales agreements and the potential impact of market conditions on future performance remain a risk.

5. Notable Q&A Insights

  • Management clarified that the drawdown on the investment management agreement was related to turnaround expenses, and they expect to cover future distributions from operational cash flow without further drawdowns.
  • Future growth initiatives may be financed through a combination of new unit issuance and leveraging the balance sheet, following the established practice of monetizing portions of OpCo interest.

This summary encapsulates the key points from the earnings call, providing a clear view of Westlake Chemical Partners' financial performance, strategic direction, and outlook for the upcoming year.